Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01169727
Other study ID # NIS-RTH-DUM-2009/2
Secondary ID
Status Completed
Phase N/A
First received July 23, 2010
Last updated May 30, 2012
Start date July 2010
Est. completion date March 2012

Study information

Verified date May 2012
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Thailand: Khon Kaen University Ethics Committee for Human ResearchThailand: Ministry of Public Health
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate health status of uncontrolled Chronic Obstructive Pulmonary Disease (COPD) patients in response to treatments in clinical practice.


Description:

MC MD


Recruitment information / eligibility

Status Completed
Enrollment 684
Est. completion date March 2012
Est. primary completion date March 2012
Accepts healthy volunteers No
Gender Both
Age group 41 Years and older
Eligibility Inclusion Criteria:

1. Provision of informed consent prior to any study specific procedures

2. Male or non-pregnant female aged >40 years

3. A clinical diagnosis of COPD with FEV1/ FVC <0.70 and require combination or modified therapy

4. Smoke > 10 Pack Year

Exclusion Criteria:

1. Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)

2. Participation in a clinical study (precluding non-interventional study or registry) during the last 3 months

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Thailand Research Site Hat Yai Songkla
Thailand Research Site Maung Trang
Thailand Research Site Maung Phuket
Thailand Research Site Maung Rayong
Thailand Research Site Maung Sakolnakorn
Thailand Research Site Maung Chantaburi
Thailand Research Site Maung Chiang Mai
Thailand Research Site Maung Chiang Rai
Thailand Research Site Maung Nakhon Sri Thammarat
Thailand Research Site Maung Nakhonratchasima
Thailand Research Site Maung Nakhonsawan
Thailand Research Site Maung Nonthaburi
Thailand Research Site Muang Phitsanulok
Thailand Research Site Muang Chonburi
Thailand Research Site Muang Khon Kaen
Thailand Research Site Ongkharak Nakhon Nayok
Thailand Research Site Prannok, Bangkok
Thailand Research Site SaiMai Bangkok
Thailand Research Site Song Phi Nong Suphan Buri
Thailand Research Site Watana Bangkok

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in PEF and overall CCQ score between the first visit and after 12 (plus or minus 1) weeks No
Secondary Difference of the changes of PEF and overall CCQ score comparing between various treatments between the first visit and after 12 (plus or minus 1) weeks No
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy